<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution-wrap>
    <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
    <institution>National Institute of Allergy and Infectious Diseases</institution>
   </institution-wrap>
  </funding-source>
  <award-id>R37 AI032042</award-id>
  <principal-award-recipient>
   <name>
    <surname>Halloran</surname>
    <given-names>M. Elizabeth</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>CP was paid by Ecole Normale Supérieur de Cachan and supported by Vaccine Research Institute (
  <ext-link ext-link-type="uri" xlink:href="http://vaccine-research-institute.fr/en/" xmlns:xlink="http://www.w3.org/1999/xlink">http://vaccine-research-institute.fr/en/</ext-link>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MEH is partially supported by National Institute of Allergy and Infectious Diseases/NIH R37 AI032042. Sanofi Pasteur (
  <ext-link ext-link-type="uri" xlink:href="http://www.sanofipasteur.com/en/" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.sanofipasteur.com/en/</ext-link>) provided support in the form of salaries for authors [EL, RLO, CF, MC, LC] or indirectly as funding to the institutions to support the work in CYD14 and CYD15 trials [ZM, PBG, PP, MRC, GC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.
 </funding-statement>
</funding-group>
